Treatment strategies in recurrent esophageal or junctional cancer

被引:22
作者
Butter, R. [1 ,2 ]
Lagarde, S. M. [1 ,7 ]
van Oijen, M. G. H. [2 ]
Anderegg, M. C. J. [1 ]
Gisbertz, S. S. [1 ]
Meijer, S. L. [3 ]
Hulshof, M. C. C. M. [4 ]
Bergman, J. J. G. H. M. [5 ,6 ]
Henegouwen, M. I. van Berge [1 ]
van Laarhoven, H. W. M. [2 ]
机构
[1] Acad Med Ctr, Dept Surg, Amsterdam, Netherlands
[2] Acad Med Ctr, Med Oncol, Amsterdam, Netherlands
[3] Acad Med Ctr, Pathol, Amsterdam, Netherlands
[4] Acad Med Ctr, Radiotherapy, Amsterdam, Netherlands
[5] Acad Med Ctr, Gastroenterol, Amsterdam, Netherlands
[6] Erasmus MC, Rotterdam, Netherlands
[7] Erasmus MC, Dept Surg, Rotterdam, Netherlands
关键词
esophageal neoplasms; local; neoplasm metastases; neoplasm recurrence; prognosis; regression analysis; RANDOMIZED CONTROLLED-TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; SURGERY; ADENOCARCINOMA; CHEMOTHERAPY; CHEMORADIATION; COMBINATION; MULTICENTER; CARCINOMA;
D O I
10.1093/dote/dox082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Little evidence is available about survival rates in patients with recurrent disease after potentially curative surgery for esophageal or junctional cancer. Only in limited occasions, potentially curative salvage strategies are available. The aim of this study is to analyze survival rates and patterns of dissemination, and to identify independent prognostic factors in a consecutive series of patients who develop recurrent esophageal or junctional cancer. Between 1994 and 2015, patients who developed disease recurrence after neoadjuvant chemo(radio) therapy followed by radical esophagectomy for esophageal or junctional cancer were retrospectively analyzed. The Kaplan-Meier estimates were performed to calculate and compare overall survival between patients with different patterns of dissemination and to compare between different treatment strategies. Furthermore, univariate and multivariate Cox-regression analyses were performed to identify independent prognostic factors for post recurrence survival. In this study, we included 219 patients. The median overall survival of all included patients was 3.2 months (range: 0.0-101.1 months). The median overall survival in patients with exclusively locoregional recurrence (n = 23, 10.8%) was 4.9 months (range: 0.1-55.6) and 2.9 months (range: 0.0-101.1) in patients who had distant metastases (n = 189, 89.2%), P = 0.003. Patients who received treatment aimed at complete tumor eradication (n = 28, 13.7%) had a median overall survival of 13.6 months (range: 1.1-101.1) and palliative treated patients (n = 94, 46.1%) of 4.7 months (range: 0.3-25.6), P < 0.001. In a selected group of patients survival of more than 20 months was achieved. Univariate and multivariate Cox-regression analysis showed that a higher age at the diagnosis of recurrent disease (hazard ratio: 1.087, P <= 0.001), an irradical resection of the primary tumor (hazard ratio: 3.355, P = < 0.001), the number of positive lymph nodes after neoadjuvant therapy (hazard ratios: ypN2 = 1.724 (P = 0.024) and ypN3 = 2.082 (P = 0.028) and the presence of a single hematogenous distant metastases (hazard ratio: 2.281, P = 0.003) or more than one hematogenous distant metastasis (hazard ratio: 2.385, P = 0.005) were associated with a shorter postrecurrence survival. The prognosis of patients who develop recurrent esophageal or junctional cancer is poor. In a selected group of patients however relatively long survival can be achieved. This offers new perspectives to improve treatment strategies and survival rates.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 21 条
[1]   Recurrence after Esophagectomy for Adenocarcinoma: Defining Optimal Follow-Up Intervals and Testing [J].
Abate, Emmanuele ;
DeMeester, Steven R. ;
Zehetner, Joerg ;
Oezcelik, Arzu ;
Ayazi, Shahin ;
Costales, Jesse ;
Banki, Farzaneh ;
Lipham, John C. ;
Hagen, Jeffrey A. ;
DeMeester, Tom R. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (04) :428-435
[2]  
Al-Batran S-E, 2010, CANCER
[3]   The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+) [J].
Al-Batran, Salah-Eddin ;
Pauligk, Claudia ;
Homann, Nils ;
Hartmann, Joerg T. ;
Moehler, Markus ;
Probst, Stephan ;
Rethwisch, Volker ;
Stoehlmacher-Williams, Jan ;
Prasnikar, Nicole ;
Hollerbach, Stephan ;
Bokemeyer, Carsten ;
Mahlberg, Rolf ;
Hofheinz, Ralf D. ;
Luley, Kim ;
Kullmann, Frank ;
Jaeger, Elke .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (04) :835-842
[4]   Factors predicting survival in patients with advanced oesophageal cancer:: a prospective multicentre evaluation [J].
Bergquist, H. ;
Johnsson, A. ;
Hammerlid, E. ;
Wenger, U. ;
Lundell, L. ;
Ruth, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (05) :385-395
[5]   Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[6]   Survival After Recurrent Esophageal Carcinoma Has Not Improved Over the Past 18 Years [J].
Blom, Rachel L. ;
Lagarde, Sjoerd M. ;
van Oudenaarde, Kim ;
Klinkenbijl, Jean H. G. ;
Hulshof, Maarten C. ;
van Laarhoven, Hanneke W. ;
Bergman, Jacques J. ;
Busch, Olivier R. ;
Henegouwen, Mark I. van Berge .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (08) :2693-2698
[7]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[8]  
Fakhrian K, 2012, STRAHLENTHER ONKOL, V188, P136, DOI 10.1007/s00066-011-0023-x
[9]  
Ferlay J, 2013, IARC Cancer Base
[10]   Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus [J].
Hulscher, JBF ;
van Sandick, JW ;
de Boer, AGEM ;
Wijnhoven, BPL ;
Tijssen, JGP ;
Fockens, P ;
Stalmeier, PFM ;
ten Kate, FJW ;
van Dekken, H ;
Obertop, H ;
Tilanus, HW ;
van Lanschot, JJB .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1662-1669